New pricing models for generic medicines to ensure long-term healthy competitiveness in Europe

 

New pricing models for generic medicines to ensure long-term healthy competitiveness in Europe

 

New pricing models for generic medicines to ensure long-term healthy competitiveness in Europe – Strategic recommendations


One-Pager: New pricing models for generic medicines

Scientific advice for continuous innovation in known molecules

Open

Removing access barriers in Central and Eastern Europe – April 2022

Open

Eco-Pharmaco-Stewardship (EPS) initiative – Care for People and Our Environment

Open

VALUE ADDED MEDICINES ONLINE SUMMIT Empowering the healthcare community by improving existing treatments

Open

Biosimilar Medicine Market Review 2020

Open

Market Review – European Generic Medicine Markets 2020

Open

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

Open

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

Open

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

(more…)

Medicines For Europe